Study vaccine and antimalarial in healthy adults in Thailand
Part of Infections clinical trials.
This Phase 2 trial tests a malaria vaccine (PvRII/Matrix-M) and how well it trains the immune system, then follows safety and effectiveness after a controlled malaria exposure. If you qualify, you’ll be monitored closely in the hospital and receive a curative antimalarial treatment after the exposure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy Thai adult age 20 to 55
- Have red blood cells that test positive for the Duffy (DARC) marker
- Be able to read and write Thai and complete consent quiz correctly
- Have finished 2 COVID-19 vaccine doses approved by WHO
- Agree to stay in Bangkok/nearby and be admitted to the hospital for monitoring during treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
This study will expose healthy adults to a small number of mosquito bites carrying the P. vivax malaria parasite to learn how many bites are needed to cause infection. Participants will be closely monitored and treated in the hospital to ensure safety.
This trial tests a new malaria vaccine in healthy adults. It aims to see if the vaccine is safe and can protect against malaria, including using a controlled infection to test effectiveness.
This study compares two experimental malaria vaccines to see how safe they are and how well they protect adults. It may help future malaria prevention, and you would be closely monitored, including a malaria “challenge” test if you qualify.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
Hear when a new Plasmodium Vivax Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.